← Every company
Vaxcyte Inc Executive Compensation
What Vaxcyte Inc's board awarded its chief executive, and what the same award was worth once the share price had moved. Companies have had to disclose both since 2023, and they routinely differ by several times over.
PCVX on carbonthat →Latest year
2025
5 years disclosed
Awarded that year
$14.5M
Actually paid
-$26.7M
after revaluation
Across every year
$85.2M
$78M actually paid
Year by year
Newest first. A negative figure means the award lost more than its whole value over the year.
| Year | Awarded | Actually paid |
|---|---|---|
| 2025-1.9×$100 → $176 | $14.5M | -$26.7M |
| 20241.1×$100 → $313 | $39.6M | $42.7M |
| 20232.3×$100 → $240 | $12.1M | $28.1M |
| 20222.2×$100 → $183 | $13.7M | $29.7M |
| 20210.8×$100 → $91 | $5.3M | $4.3M |
Source: pay-versus-performance disclosures, read from SEC XBRL company facts. "Compensation actually paid" is a revaluation of awards that may never vest, not cash received — a board that awards shares and watches them halve discloses the second, smaller figure, and that is the disclosure working rather than a pay cut. Only the years a company tagged where the SEC's data can reach them appear here.
More on PCVX
Company overviewEverything on PCVX in one place, with the price.SEC filingsWhat PCVX's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat PCVX's own officers and directors buy and sell.Planned salesSales PCVX insiders have filed notice of.Who owns itEvery manager reporting a position in PCVX.Funds holding itWhich funds and ETFs hold PCVX, and how big a bet.LobbyingWhat PCVX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on PCVX's account, and who they worked for.PatentsWhat PCVX is filing at the patent office.